Cubist Systematic Strategies, LLC Fusion Pharmaceuticals Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$7.9 - $21.32 $91,529 - $247,013	-11,586 Reduced 17.17%	55,884 $1.19 Million
Q4 2023 Feb 14, 2024	BUY	$2.48 - $9.65 $167,300 - $650,989	67,460 Added 674600.0%	67,470 $648,000
Q3 2023 Nov 14, 2023	SELL	$2.37 - $4.63 $213 - $416	-90 Reduced 90.0%	10 $0
Q2 2023 Aug 14, 2023	BUY	$3.47 - $5.33 $347 - $533	100 New	100 $0
Q3 2022 Nov 14, 2022	BUY	$2.0 - $3.56 $5,800 - $10,324	2,900 New	2,900 $9,000

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.